Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Measuring Body Fat Percentage with Amazon's Halo app + Regeneron's Antibody Treatment Cuts Risk of COVID-19 Deaths

Measuring Body Fat Percentage with Amazon's Halo app + Regeneron's Antibody Treatment Cuts Risk of COVID-19 Deaths

FromXtalks Life Science Podcast


Measuring Body Fat Percentage with Amazon's Halo app + Regeneron's Antibody Treatment Cuts Risk of COVID-19 Deaths

FromXtalks Life Science Podcast

ratings:
Length:
32 minutes
Released:
Jun 23, 2021
Format:
Podcast episode

Description

In this episode, Ayesha discusses the results of a recent study that show Amazon’s Halo app can accurately estimate body fat percentage with results comparable to traditional DXA testing. The app has built-in AI algorithms that analyze images taken from a user’s smartphone, which are used to build a 3D model of the body and generate an estimate of body fat percentage within seconds. The app is easy to use and offers users the convenience of assessing their body fat composition from the comfort of their homes, instead of having to go to a clinic and wait for several days or weeks for results. The team also talked about Regeneron’s monoclonal antibody treatment for COVID-19 that has been shown to reduce the risk of deaths by 20 percent among hospitalized COVID-19 patients in results from the UK RECOVERY trial. The treatment consists of two monoclonal antibodies that target the spike protein of SARS-CoV-2. The team discussed how it is still important to research effective treatments for COVID-19 despite having vaccines because of circulating variants, and the potential for new ones, as well as continuing high case numbers in some countries. Moreover, continuing to develop new technologies and treatments will be beneficial for other current and future infectious diseases.Read the full articles here:Study Shows Amazon’s AI-Powered Halo App Can Accurately Assess Body Fat PercentageRegeneron’s COVID-19 Monoclonal Antibody Treatment First to Reduce Risk of Death in Hospitalized PatientsFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Released:
Jun 23, 2021
Format:
Podcast episode

Titles in the series (100)

This Life Science focused podcast brings together Xtalks editorial staff to share insights into the latest B2B industry news. Xtalks connects professionals in the life science, medical device, and food industries with useful content like webinars, job opening, articles and virtual meetings.